The established cutoff value of 0.68 ng/mL demonstrated a relatively balanced sensitivity (62.3%) and specificity (63.0%), suggesting the potential of serum NLRP3 as a biomarker for identifying patients at risk of hypertension. This evidence concerns the gene NLRP3 and Hypertension.